Orca Bio

Menlo Park, United States

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

$250.0M raised

Jan 2026

Series F

Top Investors

Lightspeed Venture Partners8VCFelicisMubadalaDCVC Bio

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Orca Bio raised?

Orca Bio has raised $250.0M in total funding. The most recent round was Series F. The last funding was announced in January 2026.

Who are Orca Bio's investors?

Orca Bio's investors include Lightspeed Venture Partners, 8VC, Felicis, Mubadala, DCVC Bio.

Where is Orca Bio headquartered?

Orca Bio is headquartered in Menlo Park, United States.

What does Orca Bio do?

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

What stage is Orca Bio at?

Orca Bio is at the Series F stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2026.

MLA

"Orca Bio — Funding & Investors." VCBacked, January 9, 2026, https://www.vcbacked.co/company/orca-bio. Accessed June 3, 2026.

APA

VCBacked. (2026). Orca Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/orca-bio

Wikipedia (cite web)

{{cite web |title=Orca Bio — Funding & Investors |url=https://www.vcbacked.co/company/orca-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2026.